Jun 06,2022

Real-world data backs Medtronic’s next-gen MiniMed 780G insulin pump

According to a news release, the MiniMed 780G advanced hybrid closed loop system, designed with meal detection technology and automatic adjustments and corrections to glucose levels every five minutes, demonstrated improvements in glycemic outcomes that met consensus guideline recommendation of 70% time in range with less user interaction.

CLINICAL STUDY

#closed loop

View Analyst & Ambassador Comments
Go to original news
Jun 06,2022

LifeScan Presents Real-World Findings Showing Significantly Improved Glycemic Control in People Using OneTouch Verio Flex® blood glucose meter with the OneTouch Reveal® Mobile Application

LifeScan, a world leader in blood glucose monitoring, today announced the presentation of new real-world evidence from patient-generated data showing significantly improved readings in range and lower mean glucose in people using the OneTouch Verio Flex® blood glucose meter with the OneTouch Reveal® mobile application – the late-breaking abstract was presented at the 82nd Scientific Sessions of the American Diabetes Association (ADA) in New Orleans.

CLINICAL STUDY

#bgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 06,2022

Control-IQ Technology Continues to Demonstrate Positive and Sustained Real-World Benefits Across Diverse Cohorts of People with Diabetes

Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, announced positive real-world data demonstrating immediate and sustained benefits in a diverse cohort of people using the t:slim X2™ insulin pump with Control-IQ® technology. The data was presented at the American Diabetes Association (ADA) 82nd Scientific Sessions in New Orleans.

CLINICAL STUDY

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Jun 07,2022

Included Health Expands Platform Connectivity with the Healthcare Ecosystem to Deliver Better Member Care

Included Health, the only integrated virtual care and navigation platform, today announced it has launched a new partner ecosystem platform feature that enables deep data and app integration capabilities with select healthcare partners, including Virta Health.

COLLABORATION PARTNERSHIP

#institution

#virtual care

View Analyst & Ambassador Comments
Go to original news
Jun 07,2022

Better Therapeutics Appoints Frank Karbe as Chief Executive Officer

Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root causes of cardiometabolic diseases, today announced that Frank Karbe will join the company as President and Chief Executive Officer and serve as a member of the Board of Directors starting July 5th, 2022.

View Analyst & Ambassador Comments
Go to original news
Jun 07,2022

Dexcom CEO expects ‘science boom’ with CGM, automated insulin delivery

CEO of Dexcom Kevin Sayer has seen the integration of CGM with automated insulin delivery through partnerships with Insulet and Tandem Diabetes Care and he believes that, with pump penetration not yet passing 50% of intensive insulin users, room for growth remains.

View Analyst & Ambassador Comments
Go to original news
Jun 08,2022

Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD 8)

The study evaluated whether patients with type 1 diabetes managed with multiple daily insulin injections (MDI) exercised more after initiating continuous glucose monitoring (CGM) and whether the improved glycemic control and well-being associated with CGM translates into improved blood lipids and markers of inflammation.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Jun 09,2022

DarioHealth Secures $50 Million Dollar Non-Dilutive Credit Facility with OrbiMed

DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today it closed a senior secured term loan facility of up to $50 million with OrbiMed, a leading investor in the healthcare industry, providing non-dilutive capital to fund the continued development of its platform and the acceleration of its adoption in the multi-billion dollar global chronic disease management market.

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
Jun 09,2022

Data supports Beta Bionics’ iLet bionic pancreas

Beta Bionics announced today that a trial of its iLet bionic pancreas met key endpoints, including reduced HbA1c. Dr. Roy W. Beck and clinical investigators presented the results of the multi-center, randomized Insulin-Only Bionic Pancreas Pivotal Trial (IO BPPT) at the American Diabetes Association (ADA) 82nd Scientific Sessions in New Orleans.

CLINICAL STUDY

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Jun 09,2022

Better Therapeutics Announces Issuance of U.S. Patent Covering Key Features of Their Prescription Digital Therapeutics Platform

Better Therapeutics announced that the U.S. Patent and Trade Office (USPTO) has granted their first patent, granting twenty years of exclusivity for a number of key features core to the company’s digital therapeutics platform, designed to help treat cardiometabolic diseases through the delivery of digital behavioral therapy as a PDT.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES